About
MFX develops the Cyto Engine, a scalable automated bioprocessing platform and analytics suite to accelerate cell and gene therapy development and manufacturing. Its MFX bioreactors are prototypes in development and the site states the technology is for research & development use only.
Explore MFX (microfluidx Ltd)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.